TMCnet News

Follicular Lymphoma - Pipeline Review - Comparative Analysis, Therapeutics Assessment, Mechanism of Action & Route of Administration - Research and Markets
[January 29, 2016]

Follicular Lymphoma - Pipeline Review - Comparative Analysis, Therapeutics Assessment, Mechanism of Action & Route of Administration - Research and Markets


Research and Markets (http://www.researchandmarkets.com/research/xksdwh/follicular) has announced the addition of the "Follicular Lymphoma - Pipeline Review, H2 2015" report to their offering.

This report provides comprehensive information on the therapeutic development for Follicular Lymphoma , complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases.

It also reviews key players involved in the therapeutic development for Follicular Lymphoma and special features on late-stage and discontinued projects.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce firt-in-class and best-in-class products.



Companies Mentioned:

  • AbbVie Inc.
  • Affimed Therapeutics AG
  • Bayer AG
  • BeiGene(Beijing) Co.,Ltd
  • Bio-Path Holdings, Inc.
  • Biocon Limited
  • Biogenomics Limited
  • Biothera, Inc.
  • Boehringer Ingelheim GmbH
  • Bristol-Myers Squibb Company
  • Celgene Corporation
  • Celltrion, Inc.
  • Cellular Biomedicine Group, Inc.
  • Coherus BioSciences, Inc.
  • CTI (News - Alert) BioPharma Corp.
  • Curis, Inc.
  • Dynavax Technologies Corporation
  • (30+ Others)

Key Topics Covered:


  1. Introduction
  2. Follicular Lymphoma Overview
  3. Therapeutics Development
  4. Pipeline Products for Follicular Lymphoma - Overview
  5. Pipeline Products for Follicular Lymphoma - Comparative Analysis
  6. Follicular Lymphoma - Therapeutics under Development by Companies
  7. Follicular Lymphoma - Therapeutics under Investigation by Universities/Institutes
  8. Follicular Lymphoma - Pipeline Products Glance
  9. Late Stage Products
  10. Clinical Stage Products
  11. Early Stage Products
  12. Follicular Lymphoma - Products under Development by Companies
  13. Follicular Lymphoma - Products under Investigation by Universities/Institutes
  14. Follicular Lymphoma - Companies Involved in Therapeutics Development

For more information visit http://www.researchandmarkets.com/research/xksdwh/follicular


[ Back To TMCnet.com's Homepage ]